Literature DB >> 15604429

Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo.

Brigitte D de Lima1, Janet S May1, Sofia Marques2,3, J Pedro Simas2,3, Philip G Stevenson1.   

Abstract

The gammaherpesviruses are characteristically latent in lymphocytes and exploit lymphocyte proliferation to establish a large, persistent pool of latent genomes. Murine gammaherpesvirus 68 (MHV-68) allows the in vivo analysis of viral genes that contribute to this and other aspects of host colonization. In this study, the MHV-68 bcl-2 homologue, M11, was disrupted either in its BH1 homology domain or upstream of its membrane-localizing C-terminal domain. Each M11 mutant showed normal lytic replication in vitro and in vivo, but had a reduction in peak splenic latency. Lower infectious-centre titres correlated with lower in vivo B-cell activation, lower viral genome loads and reduced viral tRNA expression. This was therefore a true latency deficit, rather than a deficit in ex vivo reactivation. Stable, long-term levels of splenic latency were normal. M11 function therefore contributed specifically to viral latency amplification in infected lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15604429     DOI: 10.1099/vir.0.80480-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Gammaherpesvirus 68 infection of endothelial cells requires both host autophagy genes and viral oncogenes for optimal survival and persistence.

Authors:  Andrea Luísa Suárez; Raymond Kong; Tad George; Liqiang He; Zhenyu Yue; Linda Faye van Dyk
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.

Authors:  Laurie T Krug; Christopher M Collins; Lisa M Gargano; Samuel H Speck
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 3.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

4.  Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

Authors:  Qiming Liang; Brian Chang; Patrick Lee; Kevin F Brulois; Jianning Ge; Mude Shi; Mary A Rodgers; Pinghui Feng; Byung-Ha Oh; Chengyu Liang; Jae U Jung
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.

Authors:  Anastasia Gelgor; Inna Kalt; Shir Bergson; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency.

Authors:  Qingmei Jia; Michael L Freeman; Eric J Yager; Ian McHardy; Leming Tong; DeeAnn Martinez-Guzman; Tammy Rickabaugh; Seungmin Hwang; Marcia A Blackman; Ren Sun; Ting-Ting Wu
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

7.  Murine gammaherpesvirus 68 infection of gamma interferon-deficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes.

Authors:  Katherine S Lee; Carlyne D Cool; Linda F van Dyk
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68.

Authors:  Xiaofei E; Seungmin Hwang; Soohwan Oh; Jong-Soo Lee; Joseph H Jeong; Yousang Gwack; Timothy F Kowalik; Ren Sun; Jae U Jung; Chengyu Liang
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

9.  Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection.

Authors:  Nathalie Jacobs; Nathan W Bartlett; Richard H Clark; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

10.  In vivo imaging of murid herpesvirus-4 infection.

Authors:  Ricardo Milho; Christopher M Smith; Sofia Marques; Marta Alenquer; Janet S May; Laurent Gillet; Miguel Gaspar; Stacey Efstathiou; J Pedro Simas; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.